Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Introduction

The rising economic burden of cancer on healthcare system and patients in India has led to the increased demand for evidence in order to inform policy decisions such as drug price regulation, setting reimbursement package rates under publicly financed health insurance schemes and prioritising available resources to maximise value of investments in health. Economic evaluations are an integral component of this important evidence. Lack of existing evidence on healthcare costs and health-related quality of life (HRQOL) makes conducting economic evaluations a very challenging task. Therefore, it is imperative to develop a national database for health expenditure and HRQOL for cancer.

Methods and analysis

The present study proposes to develop a National Cancer Database for Cost and Quality of Life (CaDCQoL) in India. The healthcare costs will be estimated using a patient perspective. A cross-sectional study will be conducted to assess the direct out-of-pocket expenditure (OOPE), indirect cost and HRQOL among cancer patients who will be recruited at seven leading cancer centres from six states in India. Mean OOPE and HRQOL scores will be estimated by cancer site, stage of disease and type of treatment. Economic impact of cancer care on household financial risk protection will be assessed by estimating prevalence of catastrophic health expenditures and impoverishment. The national database would serve as a unique open access data repository to derive estimates of cancer-related OOPE and HRQOL. These estimates would be useful in conducting future cost-effectiveness analyses of management strategies for value-based cancer care.

Ethics and dissemination

Approval was granted by Institutional Ethics Committee vide letter no. PGI/IEC-03/2020-1565 of Post Graduate Institute of Medical Education and Research, Chandigarh, India. The study results will be published in peer-reviewed journals and presented to the policymakers at national level.

Related collections

Most cited references 46

Record: found
Abstract: not found
Article: not found

EuroQol: the current state of play

Richard Brooks (1996)

0 comments Cited 541 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: not found
Article: not found

EQ-SD: a measure of health status from the EuroQol Group

Rosalind Rabin, Frank de Charro (2009)

0 comments Cited 365 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.

Pricivel Carrera, Hagop Kantarjian, Victoria Blinder (2018)

"Financial toxicity" has now become a familiar term used in the discussion of cancer drugs, and it is gaining traction in the literature given the high price of newer classes of therapies. However, as a phenomenon in the contemporary treatment and care of people with cancer, financial toxicity is not fully understood, with the discussion on mitigation mainly geared toward interventions at the health system level. Although important, health policy prescriptions take time before their intended results manifest, if they are implemented at all. They require corresponding strategies at the individual patient level. In this review, the authors discuss the nature of financial toxicity, defined as the objective financial burden and subjective financial distress of patients with cancer, as a result of treatments using innovative drugs and concomitant health services. They discuss coping with financial toxicity by patients and how maladaptive coping leads to poor health and nonhealth outcomes. They cover management strategies for oncologists, including having the difficult and urgent conversation about the cost and value of cancer treatment, availability of and access to resources, and assessment of financial toxicity as part of supportive care in the provision of comprehensive cancer care. CA Cancer J Clin 2018;68:153-165. © 2018 American Cancer Society.

0 comments Cited 225 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Journal ID (nlm-ta): BMJ Open

Journal ID (iso-abbrev): BMJ Open

Journal ID (hwp): bmjopen

Journal ID (publisher-id): bmjopen

Title: BMJ Open

Publisher: BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )

ISSN (Electronic): 2044-6055

Publication date Collection: 2021

Publication date (Electronic): 29 July 2021

Volume: 11

Issue: 7

Electronic Location Identifier: e048513

Affiliations

[1 ] departmentDepartment of Community Medicine and School of Public Health , Post Graduate Institute of Medical Education and Research , Chandigarh, Chandigarh, India

[2 ] departmentDepartment of Radiation Oncology , Government Medical College and Hospital , Chandigarh, Chandigarh, India

[3 ] departmentDepartment of Medical Oncology , Cancer Institute-WIA , Chennai, Tamil Nadu, India

[4 ] departmentDepartment of Medical Oncology , Christian Medical College Vellore , Vellore, Tamil Nadu, India

[5 ] departmentDepartment of Clinical Pharmacology , Tata Memorial Centre , Mumbai, Maharashtra, India

[6 ] departmentDepartment of Health Research , India Ministry of Health and Family Welfare , New Delhi, Delhi, India

[7 ] departmentDepartment of Medical Oncology , Dr B Borooah Cancer Society Trust , Guwahati, Assam, India

[8 ] departmentDepartment of Medical Oncology , AIIMS , New Delhi, Delhi, India

[9 ] departmentRadiotherapy and Oncology , Government Medical College and Hospital , Chandigarh, Chandigarh, India

[10 ] departmentDepartment of Internal Medicine , Post Graduate Institute of Medical Education and Research , Chandigarh, Chandigarh, India

[11 ] departmentMedical Oncology , Tata Memorial Hospital , Mumbai, Maharashtra, India

[12 ] departmentDepartment of Gynaecologic Oncology , Dr B Borooah Cancer Society Trust , Guwahati, Assam, India

[13 ] departmentDepartment of General Surgery , Post Graduate Institute of Medical Education and Research , Chandigarh, Chandigarh, India

Author notes

[Correspondence to ] Dr Shankar Prinja; shankarprinja@ 123456gmail.com

Author information

Shankar Prinja http://orcid.org/0000-0001-7719-6986

Sudeep Gupta http://orcid.org/0000-0002-6742-6378

Article

Publisher ID: bmjopen-2020-048513

DOI: 10.1136/bmjopen-2020-048513

PMC ID: 8323373

PubMed ID: 34326050

SO-VID: b6dff83a-e40b-41bf-8ede-e12cd8b44382

License:

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

History

Date received : 29 December 2020

Date accepted : 14 July 2021

Funding

Funded by: Department of Health Research, Ministry of Health and Family Welfare, Government of India;

Award ID: F.No.T.11011/02/2017-HR/3100291

Custom metadata

special-feature unlocked

ScienceOpen disciplines: Medicine

Keywords: health economics,protocols & guidelines,public health,radiation oncology,health policy

Data availability:

ScienceOpen disciplines: Medicine

Keywords: health economics, protocols & guidelines, public health, radiation oncology, health policy

Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol

Read this article at

Abstract

Introduction

Methods and analysis

Ethics and dissemination

Related collections

Climate Change and Human Health

Most cited references 46

EuroQol: the current state of play

EQ-SD: a measure of health status from the EuroQol Group

The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.

Author and article information

Journal

Affiliations

Author notes

Author information

Article

History

Funding

Categories

Custom metadata

Comments

Comment on this article

Similar content 76

Cited by 11

Most referenced authors 481